Cancer Risk Assessment (CARISA)

CARISA is a powerful online toolkit that empowers individuals to assess their personal risk of developing cancer. With its user-friendly interface, this toolkit provides essential information, tools, and resources to help you make informed decisions about your health and well-being. Focused on Sarawak, CARISA offers five types of localised cancer risk assessments, including nasopharyngeal, colorectal, lung, breast, and cervical cancers. Discover your cancer risk today with CARISA.

Learn More

More About CARISA

CARISA is the embodiment of a local Sarawak healthcare vision that embraces a comprehensive and holistic approach to cancer awareness and management. By harnessing scientific knowledge, data analytics, artificial intelligence, and Web2.0 technologies, CARISA offers the public a personalised cancer risk assessment tool. Experience the power of CARISA and gain valuable insights into your cancer risk today.

This quick and efficient assessment toolkit will provide an approximate ranking for various types of cancer. After completing it, you’ll get an advice on whether to consult with your doctor or healthcare professional. Should you experience specific concerns in different areas of your body, feel free to retake the assessment to evaluate each region independently. Start your risk analysis now and take charge of your health.

Our Mission

The cancer problem has always been a case of “too late too bad” but it does not have to be that way. All types of cancer can be effectively managed when detected early. They can even be prevented. If we know our risk level before we get sick, steps can be taken to prevent ourselves from having cancer. Information is also powerful weapon to fight cancer disease. Therefore, it has been our cardinal mission to educate the public on the important of health awareness and self-driven desire to conduct personal risk assessment related to cancer susceptibility.

In all human endeavours (personal or professional context), risk assessment are routine standard operating procedure. However, in the context of personal health, risk assessment agenda is often side-lined and we only seek help and advice when illnesses happen. With the rapid advancement of big data technology, it has become possible to innovate non-invasive methods for self-assessment of cancer risk. This has been the impetus for us to create CARISA – a user-friendly tool in multi-language format for self-assessment of cancer risk for the five types of cancer (nasopharyngeal, colorectal, lung, breast, and cervical cancers). CARISA empowers each and every person to know their risk of getting cancers prior to seeking advice from health professionals with the aim of fostering behavioural change towards a healthier lifestyle in the community. It is part of the total and holistic approach in managing the cancer problem.

Overview of CARISA

CARISA tool is STRICTLY and ONLY for assessing personal cancer risk.

Users must consult licenced medical professionals and doctors for cancer diagnosis.

Nasopharyngeal cancer develops in the throat, mouth, lips, sinuses, or nose. Most cases are caused by tobacco, alcohol, or infection with HPV.

Breast cancer is one of the most common cancers that affect women and can develop into a hard lump in any part of the breast tissue.

There are a few different types of lung cancer, each of which may be created differently. Smoking is a major risk factor for developing lung cancer.

Colon cancer is one of the most common cancers found in men and women and occurs in the large intestine, which helps digest food.

The cervix is a tissue that connects the uterus and vagina. Cervical cancer is often caused by human papillomavirus (HPV) infections.

About

The foundation for CARISA analysis and assessment is based on the findings of pattern and behavioural studies on cancer done by the Prof. Edmund Sim, Principal Investigator in Molecular Biology, Medical Genetics and Cancer Genetics.

REFERENCE

Sim, Edmund & Ting, Su-Hie. (2018). Patterns and Determinants of Attitudes towards Genetic Risk of Cancer: Case Study in a Malaysian Public University. BioMed Research International. 2018. 1-7. 10.1155/2018/4682431.

Copyright © 2023